Largest pharmaceutical companies in the United States by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by net assets, at TRY 4.37T, ahead of Johnson & Johnson (TRY 4.12T) and Merck & Co (TRY 2.66T). Figures as of 20 Nov 2026, 01:52 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerTRY 4.37T
- Median
- TRY 33B
- Combined market value
- TRY 188.86T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | TRY 4.37T | TRY 7.94T | TRY 1,392.21 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | TRY 4.12T | TRY 32.51T | TRY 13,504.51 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | TRY 2.66T | TRY 16.55T | TRY 6,713.84 | 3.61% down | 45% up | ||
| 4 | Abbott LaboratoriesABT · Health Care | TRY 2.64T | TRY 9.09T | TRY 5,250.86 | 0.58% down | 16% down | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | TRY 1.58T | TRY 4.83T | TRY 46,676.87 | 2.35% down | 28% up | ||
| 6 | Eli LillyLLY · Health Care | TRY 1.34T | TRY 60.84T | TRY 68,302.09 | 2.29% down | 33% up | ||
| 7 | Vertex PharmaceuticalsVRTX · Health Care | TRY 943.6B | TRY 6.67T | TRY 26,320.51 | 2.94% down | 27% up | ||
| 8 | Bristol-Myers SquibbBMY · Health Care | TRY 933.9B | TRY 6.03T | TRY 2,949.22 | 2.05% down | 30% up | ||
| 9 | ViatrisVTRS · Health Care | TRY 743.7B | TRY 1.15T | TRY 1,004.98 | 1.97% down | 99% up | ||
| 10 | Royalty PharmaRPRX · Health Care | TRY 491.1B | TRY 1.97T | TRY 3,423.39 | 1.38% down | 79% up | ||
| 11 | United TherapeuticsUTHR · Health Care | TRY 358.7B | TRY 1.2T | TRY 28,263.74 | 3.16% down | 22% up | ||
| 12 | Elanco Animal HealthELAN · Health Care | TRY 331B | TRY 664.3B | TRY 1,329.02 | 1.54% down | 26% up | ||
| 13 | BioMarin PharmaceuticalBMRN · Health Care | TRY 307.7B | TRY 601.4B | TRY 3,104.92 | 0.02% down | 17% up | ||
| 14 | ZoetisZTS · Health Care | TRY 168.4B | TRY 1.66T | TRY 4,084.11 | 5.59% down | 26% down | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | TRY 51.4B | TRY 290.2B | TRY 14,505.45 | 3.94% down | 50% up | ||
| 16 | Legend BiotechLEGN · Health Care | TRY 50.7B | TRY 157.9B | TRY 813.89 | 0.92% down | 41% down | ||
| 17 | Praxis Precision MedicinesPRAX · Health Care | TRY 44.4B | TRY 439.3B | TRY 15,716.68 | 1.87% up | 86% up | ||
| 18 | Alnylam PharmaceuticalsALNY · Health Care | TRY 39.9B | TRY 1T | TRY 7,472.63 | 1.06% down | 66% down | ||
| 19 | Belite BioBLTE · Health Care | TRY 38.9B | TRY 310.1B | TRY 7,634.39 | 3.33% down | 43% up | ||
| 20 | InsmedINSM · Health Care | TRY 37.4B | TRY 1.6T | TRY 7,302.77 | 20.58% up | 40% down | ||
| 21 | Spyre TherapeuticsSYRE · Health Care | TRY 36.2B | TRY 468.7B | TRY 4,935.41 | 3.77% down | 332% up | ||
| 22 | Summit TherapeuticsSMMT · Health Care | TRY 33.3B | TRY 427.3B | TRY 534.34 | 0.67% up | 36% down | ||
| 23 | TG TherapeuticsTGTX · Health Care | TRY 32.8B | TRY 495.7B | TRY 3,279.83 | 1.88% down | 117% up | ||
| 24 | Corcept TherapeuticsCORT · Health Care | TRY 32.7B | TRY 359.5B | TRY 3,284.88 | 4.15% down | 10% down | ||
| 25 | Cogent BiosciencesCOGT · Health Care | TRY 32.2B | TRY 244B | TRY 1,402.32 | 0.25% down | 20% down | ||
| 26 | Protagonist TherapeuticsPTGX · Health Care | TRY 31.1B | TRY 409.2B | TRY 6,269.48 | 2.47% down | 51% up | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 30.5B | TRY 465.9B | TRY 20,056.08 | 0.34% down | 27% down | ||
| 28 | Edgewise TherapeuticsEWTX · Health Care | TRY 26.4B | TRY 227.9B | TRY 2,081.23 | 0.48% down | 86% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | TRY 24.9B | TRY 241.5B | TRY 4,288.34 | 1.01% up | 108% up | ||
| 30 | Ionis PharmaceuticalsIONS · Health Care | TRY 24.7B | TRY 229.2B | TRY 1,376.03 | 0.62% down | 63% down | ||
| 31 | Oruka TherapeuticsORKA · Health Care | TRY 23.9B | TRY 334.5B | TRY 4,932.38 | 1.91% up | 255% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 23.6B | TRY 311.9B | TRY 2,206.60 | 1.25% up | 13% up | ||
| 33 | Definium TherapeuticsDFTX · Health Care | TRY 16.8B | TRY 204B | TRY 1,490.28 | 1.24% up | 168% up | ||
| 34 | ErascaERAS · Health Care | TRY 16.4B | TRY 252.3B | TRY 718.85 | 3.34% up | 395% up | ||
| 35 | Mirum PharmaceuticalsMIRM · Health Care | TRY 15.9B | TRY 315.2B | TRY 4,828.24 | 3.27% up | 34% up | ||
| 36 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 7B | TRY 409.4B | TRY 5,904.50 | 1.88% down | 18% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | TRY 5.8B | TRY 234.4B | TRY 2,441.67 | 3.86% down | 45% up | ||
| 38 | Axsome TherapeuticsAXSM · Health Care | TRY 4.5B | TRY 360.8B | TRY 6,858.92 | 1.25% up | 6% down | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | -TRY 3.6B | TRY 376.7B | TRY 1,081.31 | 2.24% down | 90% up | ||
| 40 | VeradermicsMANE · Health Care | -TRY 6.1B | TRY 265.3B | TRY 6,288.19 | 0.38% down | 231% up | ||
| 41 | PTC TherapeuticsPTCT · Health Care | -TRY 10.4B | TRY 246.3B | TRY 2,948.46 | 3.16% down | 21% down | ||
| 42 | CytokineticsCYTK · Health Care | -TRY 33.3B | TRY 362.4B | TRY 2,601.42 | 0.27% up | 19% down | ||
| 43 | BridgeBio PharmaBBIO · Health Care | -TRY 105.5B | TRY 769.9B | TRY 3,952.17 | 0.22% up | 21% up | ||
| 44 | AbbVieABBV · Health Care | -TRY 165.3B | TRY 25.34T | TRY 14,333.57 | 0.86% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.5522 TRY).
Questions and answers
Which pharmaceutical companies in the United States rank first by net assets?
Pfizer (TRY 4.37T), Johnson & Johnson (TRY 4.12T) and Merck & Co (TRY 2.66T) are the top three of the 44 pharmaceutical companies in the United States ranked by net assets as of 20 Nov 2026, 01:52 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by net assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by net assets have a combined market value of TRY 188.86T as of 20 Nov 2026, 01:52 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.